Feasibility and Safety of Platelet‐Rich Plasma Combined With Plaque Puncture in Peyronie's Disease: A Prospective Study
Andrology · 2026-06-25
DOI: 10.1111/andr.70293 ↗At a glance
Journal article in Andrology, published online on 2026-06-25. Written by Chevrier Armand and 3 co-authors. Institution: Department of Urology, Andrology and Kidney Transplantation, University Hospital of Besançon, Besançon, France. 22 references.
Abstract (original language)
Background
Peyronie's disease (PD) is a fibrotic disorder of the tunica albuginea causing penile curvature and functional impairment. Platelet‐rich plasma (PRP) injections have been proposed as a regenerative therapy, but current evidence remains limited and heterogeneous.
Objectives
To evaluate the feasibility and safety of intralesional PRP combined with plaque puncture in men with stable PD, and to explore changes in penile curvature and patient‐reported outcomes. Materials and Methods Prospective single‐center interventional cohort study including 40 men with stable PD and measurable curvature ≥15°. Patients received three monthly intralesional injections of PRP combined with multisite plaque puncture. The primary endpoint was feasibility and safety, assessed by treatment completion rate and adverse events. Secondary exploratory endpoints included absolute and relative changes in penile curvature at Month 6, responder rate defined as ≥30% curvature reduction, patient satisfaction, quality of life, and predictors of response.
Results
All patients completed the planned three‐injection protocol. Adverse events occurred in 42.5% of patients and were all Clavien–Dindo grade I. Mean curvature decreased from 43.4° to 36.3° (mean reduction 7.1°, 19.2%). Eight patients (20%) achieved ≥30% curvature reduction, below the prespecified Simon framework activity threshold. Responders had lower baseline curvature and a longer disease duration. Overall satisfaction was reported by 52.5% of patients. Exploratory analyses did not demonstrate significant associations between concomitant therapies and response.
Discussion
The modest anatomical response and absence of a comparator arm preclude conclusions on PRP efficacy. Mechanical plaque puncture represents a major confounding factor, as its independent biological effect cannot be excluded. Patient profile, lower baseline curvature, and longer disease duration may influence treatment response.
Conclusion
Intralesional PRP combined with plaque puncture appears feasible and well tolerated in stable PD, with modest exploratory anatomical signals. The independent contribution of PRP cannot be determined without a sham‐controlled design, and these findings should be considered hypothesis‐generating.
Subjects
Author keywords
Authors and institutions
- Department of Urology, Andrology and Kidney Transplantation, University Hospital of Besançon, Besançon, France.
- University of Franche-Comté, Besançon, France.
- Laboratory of Nanomedicine, Imaging and Therapeutics, Besançon, France.
ORCID profiles: Chevrier Armand
Cite
APA
Armand, C., Johann, B., François, K., & Alexandre, F. (2026). Feasibility and Safety of Platelet‐Rich Plasma Combined With Plaque Puncture in Peyronie's Disease: A Prospective Study. Andrology. https://doi.org/10.1111/andr.70293
Vancouver
Armand C, Johann B, François K, Alexandre F. Feasibility and Safety of Platelet‐Rich Plasma Combined With Plaque Puncture in Peyronie's Disease: A Prospective Study. Andrology. 2026. doi:10.1111/andr.70293
BibTeX
@article{Armand2026,
author = {Armand, Chevrier and Johann, Barkatz and François, Kleinclauss and Alexandre, Frontczak},
title = {Feasibility and Safety of Platelet‐Rich Plasma Combined With Plaque Puncture in Peyronie's Disease: A Prospective Study},
journal = {Andrology},
year = {2026},
doi = {10.1111/andr.70293}
}
EUVIMED